CIM LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Buy |
633
+158
| +33% | +$70.3K | 0.04% | 148 |
|
|
2025
Q1 | $230K | Sell |
475
-2,719
| -85% | -$1.32M | 0.03% | 144 |
|
|
2024
Q4 | $1.29M | Buy |
3,194
+243
| +8% | +$97.9K | 0.18% | 91 |
|
|
2024
Q3 | $1.37M | Buy |
2,951
+4
| +0.1% | +$1.86K | 0.2% | 79 |
|
|
2024
Q2 | $1.38M | Buy |
2,947
+42
| +1% | +$19.7K | 0.21% | 76 |
|
|
2024
Q1 | $1.21M | Buy |
2,905
+62
| +2% | +$25.9K | 0.18% | 81 |
|
|
2023
Q4 | $1.21M | Buy |
2,843
+101
| +4% | +$43.1K | 0.19% | 78 |
|
|
2023
Q3 | $954K | Buy |
2,742
+111
| +4% | +$38.6K | 0.18% | 84 |
|
|
2023
Q2 | $926K | Hold |
2,631
| – | – | 0.17% | 90 |
|
|
2023
Q1 | $829K | Sell |
2,631
-3
| -0.1% | -$945 | 0.16% | 91 |
|
|
2022
Q4 | $768K | Sell |
2,634
-34
| -1% | -$9.91K | 0.15% | 97 |
|
|
2022
Q3 | $838K | Sell |
2,668
-517
| -16% | -$162K | 0.18% | 93 |
|
|
2022
Q2 | $937K | Sell |
3,185
-125
| -4% | -$36.8K | 0.19% | 87 |
|
|
2022
Q1 | $930K | Buy |
+3,310
| New | +$930K | 0.17% | 87 |
|
|
2020
Q3 | – | Sell |
-2,512
| Closed | -$729K | – | 147 |
|
|
2020
Q2 | $729K | Sell |
2,512
-48
| -2% | -$13.9K | 0.21% | 63 |
|
|
2020
Q1 | $609K | Buy |
+2,560
| New | +$609K | 0.23% | 56 |
|